Olaparib for Metastatic Breast Cancer in Patients with a Germline <i>BRCA</i> Mutation
2017 · New England Journal of Medicine · 3,073 citations
https://doi.org/10.1056/nejmoa1706450
N
Norikazu Masuda
Kyoto University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
692
Papers
29.7K
Citations
64
h-index
238
i10-index
Norikazu Masuda is an academic researcher from Kyoto University. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Breast Cancer Treatment Studies & Advanced Breast Cancer Therapies. The author has an h-index of 64, co-authored 589 publications.
ORCID: 0000-0002-7302-0278Papers by this author
worksAdjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
2017 · New England Journal of Medicine · 1,840 citations
https://doi.org/10.1056/nejmoa1612645
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
2016 · The Lancet Oncology · 1,795 citations
https://doi.org/10.1016/s1470-2045(15)00613-0
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
2020 · The Lancet · 1,743 citations
https://doi.org/10.1016/s0140-6736(20)32531-9
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
2017 · Journal of Clinical Oncology · 1,620 citations
https://doi.org/10.1200/jco.2017.73.7585
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
2018 · New England Journal of Medicine · 1,220 citations
https://doi.org/10.1056/nejmoa1810527
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat